I'll leave it to others to discuss numbers properly, but the bottom line is $700m per an.
50% market share = $350m, what are the costs? A lot less and no pharma partners to take $$$ of you
Seems like a good deal to me
...
Also, getting a product to market will be a huge milestone for MSB after years of research
This inflection point will do wonder to MSB SP & I cant wait!
Stem cells ramping up.., page-43
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |